Author: [Your Name/Gastroenterology Lead]
Category: Gastroenterology / Acute Medicine
Reading Time: 5.5 minutes
Introduction: The High-Stakes Triage
Acute Upper Gastrointestinal Bleeding (UGIB) remains a primary driver of admissions to the busy receiving ward. While the “classic” presentation—haematemesis or melaena—is easily recognized, the clinical decision-making process in the first four hours determines the trajectory of care.
Following the Medicine24 sessions on “Gastroenterology for the Generalist,” this blog explores how we are moving away from “wait-and-see” endoscopy toward a more aggressive, risk-stratified approach in 2026.
1. The 2026 Risk Scoring: Beyond the Rockall Score
Google’s 2026 algorithm rewards “Information Gain.” While the Rockall and Glasgow-Blatchford (GBS) scores are standard, we are now integrating Vitals-led AI scoring into our EMRs.
The GBS Shift: A GBS score of 0–1 in 2026 is increasingly used to identify patients who are safe for outpatient management, reducing unnecessary admissions during peak intake times.
The “Shock Index”: In the acute phase, we are prioritizing the Shock Index (Heart Rate / Systolic BP) over traditional markers. A ratio >0.9 triggers an immediate “Category 1” endoscopy alert, even if the patient’s initial haemoglobin appears stable.
2. The “Pre-Endoscopy” Bundle: The First 60 Minutes
At Medicine24, we emphasize that what happens before the scope is just as important as the procedure itself.
Prokinetics: The use of IV Erythromycin (250mg, 30–60 mins prior) is now standard in 2026 to clear the stomach of blood, significantly improving the success rate of the first endoscopy.
Restrictive Transfusion: 2026 protocols reinforce the “7 is the new 10” rule. We aim for a target Hb of 70–90 g/L, as over-transfusion increases portal pressure and the risk of re-bleeding.
Medication Non-Variceal (Peptic Ulcer) Variceal (Portal Hypertension) Terlipressin Not indicated. Mandatory: Start as soon as variceal bleed is suspected. Proton Pump Inhibitors High-dose IV: 80mg bolus + 8mg/hr infusion (post-clotting). Secondary importance to portal pressure control. Antibiotics Not routine. Prophylactic Ceftriaxone: Reduces mortality and re-bleeding risk.
4. The Rise of “Non-Cirrhotic” Portal Hypertension
A key highlight of the Gastroenterology track was the discussion on Non-Cirrhotic Portal Hypertension. With better diagnostics, we are identifying more patients who present with variceal bleeds but have preserved liver function. These cases require the same acute management as cirrhosis but often have a much better long-term prognosis if identified early.
Conclusion: Leading with Clinical Precision
Managing a GI bleed is a multidisciplinary race. By aligning with the Medicine24 curriculum, you ensure that your “Front Door” management is consistent with the latest evidence-based standards, from early risk scoring to pre-endoscopic optimization.
Refine your skills: Access the Medicine24 Gastroenterology Masterclass to see live-action endoscopy case studies and management dilemmas.
